Amyloid β protein (Aβ) deposition in dementia with Lewy bodies: Predominance of Aβ(42(43)) and paucity of Aβ40 compared with sporadic Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 24, Issue 3, 1998, Pages 187-194

  Mann, D M A ^a   Pickering Brown, S M ^a   Owen, F ^a   Baba, M ^b   Iwatsubo, T ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Dementia with Lewy bodies; Immunohistochemistry; Lewy bodies

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DEMENTIA; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; PRIORITY JOURNAL;

EID: 0031824433     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00112.x     Document Type: Article

References (42)

1. Armstrong RA, Cairns NJ, Lantos PL. Beta-amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 1997; 227: 193-6
2. Benjamin R, Leake A, Edwardson JA et al. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994; 343: 1565
3. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
4. Byrne EJ, Lennox G, Godwin-Austen RB et al. Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 1991; 2: 283-4
5. Cross RB. Demonstration of neurofibrillary tangles in paraffin section - a quick and simple method using Palmgrens technique. Med Lab Sci 1982; 39: 67-9
6. Dickson DW, Crystal H, Mattiace LA et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989; 78: 572-84
7. Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T. Amyloid β protein (Aβ) deposition in normal aging has the same characteristics as that in Alzheimer's disease: predominance of Aβ42 (43) and association of Aβ40 with cored plaques. Am J Pathol 1996; 148: 259-65
8. Galasko D, Saitoh T, Xia Y et al. The apolipoprotein E allele E4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950-1
9. Gearing M, Mori H, Mirra SS. Aβ peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1996; 39: 395-9
10. 42 is the predominant form of amyloid β-protein in the brains of short-term survivors of head injury. NeuroReport 1997; 8: 1519-22
11. Gentleman SM, Williams B, Royston MC et al. Quantification of BA4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neurosci Lett 1992; 142: 9-12
12. Hansen L, Salmon U, Galasko D et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40: 1-8
13. Hansen LA, Masliah E, Quijada-Fawcett S, Rexin D. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Neurosci Lett 1991; 129: 269-72
14. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. Amyloid β protein (Aß) deposition: Aβ42 (43) precedes Aβ40 in Down syndrome. Ann Neurol 1995; 37: 294-9
15. Iwatsubo T, Odaka N, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42 (43) -positive and Aβ40-positive senile plaques with end-specific Aβ monclonal antibodies: Evidence that an initially deposited species is Aβ-42(43), Neuron 1994; 13: 45-53
16. Iwatsubo T, Saido TC, Mann DMA, Lee VM-Y, Trojanowski JQ. Full-length Aβ (1-42 (43) ) as well as amino-terminally modified and truncated Aβ-42 (43) deposit in diffuse plaques. Am J Pathol 1996; 149: 1823-30
17. Iwatsubo T, Yamaguchi H, Fujimuro M et al. Purification and characterisation of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 1996; 148: 1517-29
18. Kida E, Wisniewski KE, Wisniewski HM. Early amyloid-β deposits show different immunoreactivity to the amino-and carboxy-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain. Neurosci Lett 1995; 193: 105-8
19. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol Dis 1996; 3: 16-32
20. 42 deposition and severe cerebellar pathology. Nature Med 1996; 2: 1146-50
21. Mahley RW. Apolipoprotein E cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-50
22. Mak K, Yang F, Vinters HV, Frautschy SA, Cole GM, Polyclonals to β-amyloid (1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res 1994; 667: 138-42
23. Mann DMA. Alzheimer's disease: progress in pathological and aetiological aspects. Rev Clin Gerontol 1994; 4: 43-60
24. Mann DMA, Iwatsubo T. Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid β protein (Aβ) only in the form of Aβ42 (43). Neurodegeneration 1996; 5: 115-20
25. Mann DMA, Snowden JS. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995; 89: 178-83
26. Mann DMA, Iwatsubo T, Fukumoto H, Suzuki N, Odaka A. Microglial cells and amyloid β protein (Aβ) deposition; association with Aβ40 containing plaques. Acta Neuropath 1995; 90: 472-7
27. Mann DMA, Iwatsubo T, Ihara Y et al. Predominant deposition of Aβ42 (43) in plaques in cases of Alzheimer's disease and hereditary cerebral haemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996; 148: 1257-66
28. 42 (43). Ann Neurol 1996; 40: 149-56
29. Mann DMA, Iwatsubo T, Snowden JS. Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies. Acta Neuropathol 1996; 91: 647-53
30. Mann DMA, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. Amyloid (Aβ) protein deposition in chromosome 1 linked Alzheimer's disease - the Volga German kindreds. Ann Neurol 1997; 41: 52-7
31. Mann DMA, Iwatsubo T, Pickering-Brown SM, Saido TC. Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with gene dosage effect of the Apolipoprotein E E4 allele. Neurosci Lett 1997; 221: 81-4
32. Marder K, Maestre G, Cote L et al. The apolipoprotein e4 allele in Parkinson's disease with and without dementia. Neurology 1994; 44: 1330-1
33. McKenzie JE, Edwards RJ, Gentleman SM et al. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of Lewy body type. Acta Neuropathol 1996; 91: 526-9
34. Morris JC, McKeel JDW, Storandt M et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991; 41: 469-78
35. Murphy GM, Forno LS, Higgins L, Scardina JM, Eng LF, Cordell B. Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994; 144: 1082-8
36. Perry RH, Irving D, Blessed G et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-39
37. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S. Amino-and carboxyl- terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci Lett 1996; 215: 173-6
38. Selkoe DJ. Normal and abnormal biology of the β amyloid precursor protein. Annu Rev Neurosci 1994; 17: 489-517
39. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994; 200: 1598-603
40. Teller JK, Russo C, de Busk LM et al. Presence of soluble amyloid β peptide precedes amyloid plaque formation in Down's syndrome. Nature Med 1996; 2: 93-5
41. Wenham PR, Price WH, Blundell C. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-9
42. Yamaguchi H, Sugiahra S, Ishiguro K, Takashima A, Hirai S. Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging. Amyloid: Int J Clin Invest 1995; 2: 7-16